51% of Ozempic users worry they must choose between medication and retirement savings
( NewsNation ) — Americans taking popular GLP-1 medications such as Ozempic, Wegovy and Zepbound may be facing a new financial dilemma: save for retirement or pay for the drugs helping improve their health. A new survey from the Nationwide Retirement Institute found that 51% of current GLP-1 users…
Fire or Trash?
Your verdict on this story. One tap, no account needed.Dumpster Fire links to reporting from newsnationnow.com. We don’t rewrite the facts; the original story is one click away.
Comments
Loading comments…
Comments are automatically checked for hate, threats and spam. Community rules.